EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$4.37
-0.06 (-1.35%)
Open$4.49
Previous Close$4.43
Day High$4.49
Day Low$4.32
52W High$13.66
52W Low$4.09
Volume—
Avg Volume1.01M
Market Cap301.88M
P/E Ratio—
EPS$-0.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+1,073.7% upside
Current
$4.37
$4.37
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 299.90M | 238.04M | 74.40M |
| Net Income | -52,113,053 | -37,226,563 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -27,175,558 | -20,491,134 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |